Form 4: Ardent Health CEO Martin Bonick Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Ardent Health CEO Martin Bonick disclosed the withholding of shares for tax obligations and the receipt of new restricted stock units.
Summary
- CEO Martin Bonick engaged in routine equity transactions related to tax withholding and compensation.
- On March 31, 2026, 8,026 shares were withheld for taxes at a price of $8.56 per share.
- On April 1, 2026, 10,952 shares were withheld for taxes at a price of $8.67 per share.
- On April 1, 2026, the CEO was granted 134,615 restricted stock units (RSUs).
- Following these transactions, the CEO holds 1,437,937 shares of Ardent Health common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation and tax obligations, having no material impact on the company's financial outlook.
Positives
- The CEO maintains a significant equity stake of 1,437,937 shares, aligning interests with shareholders.
- The grant of 134,615 RSUs serves as a long-term retention and performance incentive.
Negatives
- The withholding of shares for tax purposes is a standard administrative event and does not reflect a change in market sentiment.
Risks
- Vesting of the 134,615 RSUs is contingent upon the Reporting Person's continued service with the Issuer.
Future Outlook
The 134,615 restricted stock units are set to vest in three substantially equal installments on each anniversary of April 1, 2026, subject to continued service.
Management Comments
- The transactions reflect standard tax withholding requirements upon the vesting of restricted stock units.
Industry Context
StockSavvy.ai notes that this filing represents routine executive compensation management common in the healthcare sector, where equity-based incentives are standard for aligning leadership with long-term corporate performance.
Comparison to Industry Standards
- The use of RSU grants for executive retention is consistent with standard corporate governance practices among publicly traded healthcare providers.
- Tax withholding upon vesting is a standard regulatory compliance procedure for equity compensation.
Stakeholder Impact
- Shareholders should view this as a standard compensation event with no change to the CEO's long-term commitment to the company.
Next Steps
- Vesting of the first installment of the 134,615 RSUs on April 1, 2027.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Transaction date for tax withholding of 8,026 shares. |
| 04/01/2026 | Transaction date for tax withholding of 10,952 shares and grant of 134,615 RSUs. |
| 04/02/2026 | Filing date of the Form 4. |
Keywords
Ardent Health, ARDT, Form 4, Insider Trading, Executive Compensation, Martin Bonick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.